REGN vs UNIT
Regeneron Pharmaceuticals Inc (REGN) versus Uniti Group Inc (UNIT) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Uniti Group Inc (UNIT) is a reit - specialty company listed on NASDAQ.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported UNIT revenue for 2025-09-30 was $722.6M. Net income was $1.61B. Revenue was up 147.3% from 2024-09-30 to 2025-09-30. UNIT currently screens at market cap $2.96B and trailing P/E 2.7.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. UNIT currently screens at market cap $2.96B and trailing P/E 2.7.
Not investment advice. Open the REGN and UNIT stock pages for the full models.
Not investment advice.